Note
"Canada's Drug Strategy."
"We would like to thank the following people for their assistance with this project: Virginia Carver (Canada’s Drug Strategy Division, Health Canada) for her advice support and practical assistance throughout; Nancy Poole for her interest, support and assistance in defining, reviewing and supporting the project’s goals and content; the members of the Working Group on Accountability and Evaluation Framework and Research Agenda of the Federal/Provincial/Territorial Committee on Alcohol and Other Drug Issues for their support and assistance in identifying key experts and resources and providing input into the draft report; Bette Reimer (Canadian Centre on Substance Abuse) and Rob Harvey (B.C. Ministry for Children and Families) for their assistance in tracking reference material; all the key experts who so willingly and enthusiastically contributed to this project."
Issued also in French under title: Meilleures pratiques : traitement et réadaptation des femmes ayant des problèmes attribuables à la consommation d’alcool et d’autres drogues.
This publication may be reproduced, in whole or in part, for educational and non-commercial purposes, without permission provided the source is fully acknowledged. ©All Rights Reserved. Best practices : treatment and rehabilitation for women with substance use problems. Health Canada, 2001. Reproduced with permission from the Minister of Health, 2014.
Summary
This report identifies elements of best practice in the treatment and rehabilitation of
women with substance use problems. Best practices are identified and described in the
areas of: client outreach, contact and engagement, treatment principles, specific
approaches and methods, client retention in treatment, treatment organization and
duration, delivery of adjunctive services, and measurement of treatment effectiveness.
Recommendations for best practices are based on the results of interviews with 40 key
experts and a review of current literature related to these topic areas. Interviews with
key experts and the review of the literature also addressed barriers to treatment for
women.